Vovantis Laboratories Comprehensive Company Profile
Key Indicators
- Authorised Capital ₹ 31.00 Cr
as on 18-06-2024
- Paid Up Capital ₹ 28.50 Cr
as on 18-06-2024
- Company Age 15 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 24.86 Cr
as on 18-06-2024
- Satisfied Charges ₹ 18.78 Cr
as on 18-06-2024
- Revenue -8.48%
(FY 2023)
- Profit -119.05%
(FY 2023)
- Ebitda -56.36%
(FY 2023)
- Net Worth -1.35%
(FY 2023)
- Total Assets -11.06%
(FY 2023)
About Vovantis Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 31.00 Cr and a paid-up capital of Rs 28.50 Cr.
The company currently has active open charges totaling ₹24.86 Cr. The company has closed loans amounting to ₹18.78 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Vovantis Laboratories Private Limited India is Chintikaben Shah as COMPANY SECRETARY. Anilkumar Parekh, Vinayak Nayak, Sultan Reshamwala, and One other member serve as directors at the Company.
- CIN/LLPIN
U24230GJ2008PTC055176
- Company No.
055176
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Oct 2008
- Date of AGM
18 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Vovantis Laboratories Private Limited offer?
Vovantis Laboratories Private Limited offers a wide range of products and services, including Antipyretic Medication, Paracetamol Tablets, Digestive System Drugs & Medicines, Antispasmodic Drugs, Multivitamin Tablets & Capsules, Vitamin B Complex Tablets & Capsules, Vitamin Tablets & Capsules, Vitamin Effervescent Tablet, Dental Products, Denture Cleaners.
Who are the key members and board of directors at Vovantis Laboratories?
Executive Team (1)
CS
Chintikaben Shah
Company SecretaryAppointment Date: 02-May-2019
Status: Current
Board Members(4)
Financial Performance and Corporate Structure Insights of Vovantis Laboratories.
Vovantis Laboratories Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 8.48% decrease. The company also saw a substantial fall in profitability, with a 119.05% decrease in profit. The company's net worth dipped by a decrease of 1.35%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vovantis Laboratories?
In 2023, Vovantis Laboratories had a promoter holding of 100.00%. The company had 2 Joint Ventures. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
_PRIVATE_LIMITED.webp)
Sarabhai Chemicals (India) Private Limited
Active
20 years 8 months Anilkumar Parekh and Mohal Sarabhai are mutual person
Sarabhai M. Chemicals Limited
Active 23 years 9 months Anilkumar Parekh and Mohal Sarabhai are mutual person
_PRIVATE_LIMITED.webp)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 24 Nov 2020 | ₹12.43 Cr | Open |
Axis Bank Limited Creation Date: 27 Dec 2019 | ₹12.43 Cr | Open |
Bank Of India Creation Date: 21 Aug 2017 | ₹7.50 M | Satisfied |
How Many Employees Work at Vovantis Laboratories?
Vovantis Laboratories has a workforce of 138 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
As of Jul 22, 2019, Vovantis Laboratories has raised a total of ₹ 38.93 Cr, with the most recent deal valued at ₹ 8.45 Cr. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
